Molecular therapy for autoimmune diabetes (TIDM): Carbamazepine, an anticonvulsant drug used to treat  seizures and nerve pain such as trigeminal neuralgia and diabetic neuropathy, and bipolar disorder, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 2/October/2018, 11.48 pm